Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety‐Assessment Cohort

LESSONS LEARNED: Bintrafusp alfa had a manageable safety profile and demonstrated preliminary clinical activity in heavily pretreated patients with solid tumors (including hepatocellular carcinoma) with no or limited treatment options. Findings from this study suggest bintrafusp alfa may be a novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Doi, Toshihiko, Fujiwara, Yutaka, Koyama, Takafumi, Ikeda, Masafumi, Helwig, Christoph, Watanabe, Morihiro, Vugmeyster, Yulia, Kudo, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485354/
https://www.ncbi.nlm.nih.gov/pubmed/32324927
http://dx.doi.org/10.1634/theoncologist.2020-0249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485354/
https://www.ncbi.nlm.nih.gov/pubmed/32324927
http://dx.doi.org/10.1634/theoncologist.2020-0249

Ejemplares similares